DiscoverNPP BrainPodIntegrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl
Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl

Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl

Update: 2023-10-16
Share

Description

The drug naloxone, otherwise known as Narcan, is a critical tool in reversing fentanyl overdoses and reducing mortality. But now fentanyl is appearing on the streets adulterated with a drug called xylazine. 


Justin Strickland, assistant professor at Johns Hopkins University School of Medicine, and Cassandra Gipson-Reichardt, associate professor in the department of pharmacology nutritional sciences at the University of Kentucky, are the coauthors of a new paper in the journal Neuropsychopharmacology about the importance of integrating public health and translational science to address the challenges of xylazine adulteration of fentanyl. 


Read the full study here: https://www.nature.com/articles/s41386-023-01680-7





Hosted on Acast. See acast.com/privacy for more information.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl

Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl